Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
CC transcript
Inv. presentation
|
|
Jazz Pharmaceuticals plc (JAZZ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2023 |
4
| ORiordan Anne (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.158, valued at
$171.5k
|
|
| 08/15/2023 |
4
| O'Keefe Kenneth W (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1585, valued at
$171.5k
|
|
| 08/15/2023 |
4
| Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1584, valued at
$171.5k
|
|
| 08/15/2023 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1585, valued at
$171.5k
|
|
| 08/15/2023 |
4
| Smith Mark Douglas (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1579, valued at
$171.5k
|
|
| 08/15/2023 |
4
| RIEDEL NORBERT G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1581, valued at
$171.5k
|
|
| 08/15/2023 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0 |
|
| 08/15/2023 |
4
| McSharry Heather Ann (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,344 shares
@ $138.1586, valued at
$185.7k
|
|
| 08/15/2023 |
4
| Henderson Mary Elizabeth (SVP, Technical Operations) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 10,763 shares
@ $0 |
|
| 08/15/2023 |
4
| Gray Peter (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1584, valued at
$171.5k
|
|
| 08/15/2023 |
4
| ENRIGHT PATRICK G (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1585, valued at
$171.5k
|
|
| 08/15/2023 |
4
| Cook Jennifer E. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1581, valued at
$171.5k
|
|
| 08/15/2023 |
4
| Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 158 shares
@ $138.1575, valued at
$21.8k
|
|
| 08/09/2023 |
4
| Patil Neena M (EVP & Chief Legal Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Disposed/sold 1,390 shares
@ $131.51, valued at
$182.8k
|
|
| 06/12/2023 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Exercised 4,500 options to buy
@ $81.76, valued at
$367.9k
|
|
| 06/09/2023 |
4
| Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 126 shares
@ $127.916, valued at
$16.1k
|
|
| 06/07/2023 |
4
| Iannone Robert (EVP, Global Head of Research a) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Disposed/sold 1,311 shares
@ $129.73, valued at
$170.1k
|
|
| 06/07/2023 |
4
| Sablich Kim (EVP, GM of U.S.) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Disposed/sold 2,082 shares
@ $129.73, valued at
$270.1k
|
|
| 05/19/2023 |
4
| GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 6,000 shares
@ $131.7457, valued at
$790.5k
|
|
| 03/17/2023 |
4
| Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,023 shares
@ $133.22, valued at
$136.3k
|
|
| 03/10/2023 |
4
| Sablich Kim (EVP, GM of U.S., Commercial Ma) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,752 shares
@ $139.42, valued at
$244.3k
Sold 1,261 shares
@ $140.19, valued at
$176.8k
|
|
| 03/09/2023 |
4
| O'Keefe Kenneth W (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 2,690 shares
@ $138.3894, valued at
$372.3k
Exercised 4,500 options to buy
@ $81.76, valued at
$367.9k
|
|
| 03/07/2023 |
4
| Larkin Finbar (SVP, Technical Operations) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 4,373 shares
@ $0
Sold 1,706 shares
@ $143.919, valued at
$245.5k
Sold 2,075 shares
@ $140.7619, valued at
$292.1k
Exercised 1,706 options to buy
@ $58.72, valued at
$100.2k
|
|
| 03/07/2023 |
4
| Swisher Daniel N JR (President and COO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 13,456 shares
@ $0
Paid exercise price by delivering 5,426 shares
@ $142.78, valued at
$774.7k
|
|
| 03/07/2023 |
4
| Iannone Robert (EVP, Global Head of Research a) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 12,447 shares
@ $0
Paid exercise price by delivering 2,274 shares
@ $142.78, valued at
$324.7k
|
|
| 03/07/2023 |
4
| Carr Patricia (SVP, Chief Accounting Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,523 shares
@ $0
Sold 1,148 shares
@ $140.7612, valued at
$161.6k
|
|
| 03/07/2023 |
4
| GALA RENEE D (EVP & CFO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 12,784 shares
@ $0
Paid exercise price by delivering 1,557 shares
@ $142.78, valued at
$222.3k
|
|
| 03/07/2023 |
4
| Patil Neena M (EVP & Chief Legal Officer) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 9,419 shares
@ $0
Paid exercise price by delivering 1,923 shares
@ $142.78, valued at
$274.6k
|
|
| 03/07/2023 |
4
| Pearce Samantha (SVP, Head of Europe & Internat) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,870 shares
@ $0
Paid exercise price by delivering 2,020 shares
@ $142.78, valued at
$288.4k
|
|
| 03/07/2023 |
4
| Sablich Kim (EVP, GM of U.S., Commercial Ma) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 10,429 shares
@ $0
Paid exercise price by delivering 1,610 shares
@ $142.78, valued at
$229.9k
|
|
| 03/07/2023 |
4
| COZADD BRUCE C (Chairman & CEO) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 42,388 shares
@ $0
Paid exercise price by delivering 21,882 shares
@ $142.78, valued at
$3.1M
|
|
| 03/07/2023 |
4
| Mulligan Seamus (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Exercised 4,500 options to buy
@ $59.13, valued at
$266.1k
|
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|